U.K. switches nicotinamide
This article was originally published in The Tan Sheet
Executive SummaryThe U.K. health authority approves switching Freederm Gel PL (nicotinamide) acne treatment to OTC. The Medicines and Healthcare products Regulatory Agency Feb. 19 says it reclassified nicotinamide 4 percent topical gel from pharmacy status, similar to nonprescription behind-the-counter in the U.S., to general sale for the treatment of mild to moderate inflammatory acne vulgaris. The change follows Diomed Developments' filing of a switch application (1"The Tan Sheet" Oct, 13, 2008, In Brief)
You may also be interested in...
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.